Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
5-chloro-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}-1-benzothiophene-2-sulfonamide
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
This compound is a synthetic small molecule classified as an arylsulfonamide dipeptide derivative. It has not been approved for clinical use and is considered experimental, with no known indications or clinical trials reported. The molecule features a benzothiophene sulfonamide core substituted with a morpholine-containing side chain and a pyrrolidinone moiety. Its primary research context appears to be as a chemical probe or ligand in structural biology studies, particularly in relation to coagulation factor X (FA10_HUMAN), suggesting potential anticoagulant activity via inhibition of this serine protease involved in the blood coagulation cascade[2][4][5]. No commercial developers or manufacturers are associated with this compound.
- Other names
- DB07843DB-07843DB 07843GS5GS-5GS 5CHEBI:47442Arylsulfonamide 1bArylsulfonamide1bArylsulfonamide-1b
02
Targets
F10 (Factor Xa)
Beyond the preview
Go deeper on 5-chloro-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}-1-benzothiophene-2-sulfonamide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 5-chloro-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}-1-benzothiophene-2-sulfonamide.